From: Are IgM-enriched immunoglobulins an effective adjuvant in septic VLBW infants?
IgM-eIVIG | Treated | Untreated | ||
---|---|---|---|---|
n = 40 | n = 39 | OR (95%CI) | p | |
Short term mortality | 9 (22%) | 18 (46%) | 0.16 (0.3-0.7) | 0,005* |
Total mortality | 17 (44%) | 18 (46%) | 0.46 (0.9-1.8) | NS |
IVH | 9 (22%) | 8 (20%) | 1.17 (0.5-2.7) | NS |
PVL | 3 (7,5%) | 2 (3%) | 2.6 (0.5-14) | NS |
NEC | 2 (6%) | 1 (3%) | 2 (0.4-11) | NS |
BDP | 4(10%) | 4 (10%) | 0.97(0.2-4.2) | NS |